Bharat Biotech says its Covaxin booster dose offers long term protection

0
0

India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.

The company said a booster dose was given to trial participants six months after they received their second dose.

Credits – Source – https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/bharat-biotech-says-its-covaxin-booster-dose-offers-long-term-protection/articleshow/88779041.cms

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.